AstraZeneca 'within striking distance' of curing some cancers, CEO says | CNBC Conversation
Pascal Soriot, CEO of AstraZeneca, sits down with CNBC's Julianna Tatelbaum to discuss the hunt for a cancer cure and what gene therapy could do to transform the pharmaceutical industry.
▶︎
Pascal Soriot, AstraZeneca: Real Innovation Requires Risk
▶︎
Watch CNBC's full interview with AstraZeneca CEO Pascal Soriot
▶︎
Full Trump speech claims China 'meddling' in 2020 election, calls for investigation during address
▶︎
The CNBC Conversation with Easa Al Gurg
▶︎
Squawk Box Asia - 17-Jul-26
▶︎
England vs. Argentina Highlights FIFA World Cup 2026 | Sportschau
▶︎
Pioneering Next-Gen TCR Therapies with Neogene Therapeutics’ Carsten Linnemann, Ph.D.
▶︎
Russian Central Bank boss on risk of global recession | CNBC Conversation
▶︎
Larry Ellison: I had all the disadvantages necessary for success
▶︎
Cell Therapy Manufacturing Explained
▶︎
Pharma industry has a trust issue, AstraZeneca CEO says | CNBC Conversation
▶︎
Soriot: the CEO who fought a bid
▶︎
Behind the Scenes of Cell and Gene Therapy Manufacturing | Vertex Pharmaceuticals
▶︎
Livia Firth on why fast fashion needs to stop | CNBC Conversation
▶︎
Zuckerberg clashes with senator in heated debate over Facebook
▶︎
Novartis CEO: We're never done with M&A
▶︎
This is us. This is AstraZeneca Gothenburg
▶︎
How China's 'Perfect' Spy Got Caught | Bloomberg Investigates
▶︎
Interview with ECB President Christine Lagarde | Prime Time
▶︎